Cutler Group LP Aerie Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$5.64 - $9.8 $223,344 - $388,080	-39,600 Reduced 99.75%	100 $0
Q4 2021 Jan 18, 2022	BUY	$7.02 - $13.33 $188,136 - $357,244	26,800 Added 207.75%	39,700 $8,000
Q4 2019 Feb 06, 2020	SELL	$17.72 - $25.1 $60,247 - $85,340	-3,400 Reduced 20.86%	12,900 $59,000
Q3 2019 Oct 28, 2019	BUY	$18.41 - $28.0 $263,263 - $400,400	14,300 Added 715.0%	16,300 $41,000
Q2 2019 Aug 09, 2019	SELL	$28.97 - $48.21 $46,352 - $77,136	-1,600 Reduced 44.44%	2,000 $22,000
Q1 2019 May 10, 2019	SELL	$36.32 - $49.25 $232,448 - $315,200	-6,400 Reduced 64.0%	3,600 $18,000
Q4 2018 Feb 05, 2019	BUY	$33.0 - $60.04 $201,300 - $366,244	6,100 Added 156.41%	10,000 $11,000
Q3 2018 Nov 07, 2018	BUY	$56.15 - $73.9 $5,615 - $7,390	100 Added 2.63%	3,900 $11,000
Q2 2018 Aug 10, 2018	SELL	$47.85 - $70.45 $23,925 - $35,225	-500 Reduced 11.63%	3,800 $31,000
Q1 2018 May 11, 2018	SELL	$51.15 - $61.0 $634,260 - $756,400	-12,400 Reduced 74.25%	4,300 $13,000
Q4 2017 Jan 17, 2018	SELL	$50.85 - $65.1 $757,665 - $969,989	-14,900 Reduced 47.15%	16,700 $41,000
Q3 2017 Oct 17, 2017	BUY	$48.6 - $60.1 $1.54 Million - $1.9 Million	31,600	31,600 $75,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.